PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Systematic reviews evaluated the effectiveness and tolerability of ivy leaf in adult and pediatric populations for acute URTIs [PMID:33523253, PMID:40376625].
In a mouse model, a bioactive phenolics fraction of H. helix standardized extract ameliorated LPS-induced acute lung injury by inhibiting proinflammatory cytokines and oxidative stress [PMID:35647334].
There is some evidence for the use of Hedera helix as a non-pharmacological remedy to relieve PAC [PMID:34461702].
Safety & adverse effects
Pregnancy & lactation
Dosage & administration
Evidence summary
PubMed sources
- 1.PMID: 34981489 (2021) — The Effects of Ivy (Hedera helix) on Respiratory Problems and Cough in Humans: A Review. · Advances in experimental medicine and biology
- 2.PMID: 33523253 (2021) — Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review. · European journal of clinical pharmacology
- 3.PMID: 40376625 (2025) — Phytotherapy for acute respiratory tract infections in children: a systematically conducted, comprehensive review. · Frontiers in pediatrics
- 4.PMID: 34482524 (2021) — Safety of English ivy (Hedera helix) leaf extract during pregnancy: retrospective cohort study. · Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
- 5.PMID: 20236156